Budget 2024: After February 1, the cost of medicines will reduce, will Nirmala Sitharaman give relief in the budget?

Finance Minister Nirmala Sitharaman is going to present the Interim Budget 2024 after just two days. This time there may not be any major announcement in the budget, but it is expected that the common man can be given relief from expensive medicines in the budget.

Day by day increasing prices of medicines have made life difficult for people. Modi government has already opened Pradhan Mantri Jan Aushadhi Centers across the country. Still, it is expected that this time Finance Minister Nirmala Sitharaman will give the gift of many and especially life-saving cheap medicines to the people in the interim budget.

Actually, this time the interim budget has to be presented. In such a situation, the government would like to avoid making big announcements, but medicines are related to the common man. In such a situation, the government can provide relief to the people with cheap medicines before the elections.

There can be many solutions in the budget

To keep the cost of health care low in the country, the government can increase its health care expenditure in the budget. The government can make provision of funds for everything from health infrastructure to research and innovation. Apart from this, the government can also focus on increasing the stores of affordable medicines, promoting generic medicines and promoting local manufacturing of health products.

Affordable medicines are very important for the progress of the country. If medicines become cheaper then common people will have money left for other expenses. Dr. Gayatri Kamaineni, COO of Kamaineni Hospitals, says that the government can provide relief by reducing GST on medicines. At the same time, pharmaceutical companies can be given facilities like tax exemption for making generic medicines.

On the other hand, the government also has to pay attention to making medical equipment and devices cheaper in the country. For this, the government is also developing a medical park. Chandra Ganju, Group CEO of Trivitron Healthcare, also says that this time the government can focus on reducing the import of medical equipment and technical products. Currently, 80 to 85 percent of such products are imported in the country. Its import bill is around Rs 63,200 crore.